Geng F - Search Results

1

Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice.

Xia Q, Geng F, Zhang FF, Liu CL, Xu P, Lu ZZ, Zhang HH, Kong W, Yu XH. Xia Q, et al. Among authors: geng f. Vaccine. 2016 Aug 31;34(38):4526-4535. doi: 10.1016/j.vaccine.2016.07.054. Epub 2016 Aug 3. Vaccine. 2016. PMID: 27498213

2

Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model.

Xia Q, Zhang FF, Geng F, Liu CL, Xu P, Lu ZZ, Yu B, Wu H, Wu JX, Zhang HH, Kong W, Yu XH. Xia Q, et al. Among authors: geng f. Cancer Immunol Immunother. 2016 May;65(5):613-24. doi: 10.1007/s00262-016-1827-4. Epub 2016 Mar 28. Cancer Immunol Immunother. 2016. PMID: 27020681 Free PMC article.

3

MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model.

Zhang H, Liu C, Zhang F, Geng F, Xia Q, Lu Z, Xu P, Xie Y, Wu H, Yu B, Wu J, Yu X, Kong W. Zhang H, et al. Among authors: geng f. Vaccine. 2016 May 23;34(24):2648-55. doi: 10.1016/j.vaccine.2016.04.045. Epub 2016 Apr 22. Vaccine. 2016. PMID: 27113167

4

Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer.

Xia Q, Zhang FF, Geng F, Liu CL, Wang YQ, Xu P, Lu ZZ, Xie Y, Wu H, Chen Y, Zhang Y, Kong W, Yu XH, Zhang HH. Xia Q, et al. Among authors: geng f. Cell Immunol. 2016 Dec;310:89-98. doi: 10.1016/j.cellimm.2016.08.006. Epub 2016 Aug 16. Cell Immunol. 2016. PMID: 27545090

5

Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma.

Xia Q, Geng F, Zhang FF, Liu CL, Xu P, Lu ZZ, Xie Y, Sun B, Wu H, Yu B, Kong W, Yu XH, Zhang HH. Xia Q, et al. Among authors: geng f. Immunopharmacol Immunotoxicol. 2017 Feb;39(1):37-44. doi: 10.1080/08923973.2016.1269337. Epub 2016 Dec 22. Immunopharmacol Immunotoxicol. 2017. PMID: 28004985

6

Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect.

Liu C, Lu Z, Xie Y, Guo Q, Geng F, Sun B, Wu H, Yu B, Wu J, Zhang H, Yu X, Kong W. Liu C, et al. Among authors: geng f. Immunol Lett. 2018 Aug;200:33-42. doi: 10.1016/j.imlet.2018.06.004. Epub 2018 Jun 9. Immunol Lett. 2018. PMID: 29894719

7

A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.

Geng F, Guo J, Guo QQ, Xie Y, Dong L, Zhou Y, Liu CL, Yu B, Wu H, Wu JX, Zhang HH, Kong W, Yu XH. Geng F, et al. Vaccine. 2019 Jul 18;37(31):4382-4391. doi: 10.1016/j.vaccine.2019.06.012. Epub 2019 Jun 12. Vaccine. 2019. PMID: 31202521

8

Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model.

Geng F, Bao X, Dong L, Guo QQ, Guo J, Xie Y, Zhou Y, Yu B, Wu H, Wu JX, Zhang HH, Yu XH, Kong W. Geng F, et al. Oncoimmunology. 2020 Apr 16;9(1):1747350. doi: 10.1080/2162402X.2020.1747350. eCollection 2020. Oncoimmunology. 2020. PMID: 32363118 Free PMC article.

9

Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse.

Guo Q, Wang L, Xu P, Geng F, Guo J, Dong L, Bao X, Zhou Y, Feng M, Wu J, Wu H, Yu B, Zhang H, Yu X, Kong W. Guo Q, et al. Among authors: geng f. Oncoimmunology. 2020 Nov 9;9(1):1841392. doi: 10.1080/2162402X.2020.1841392. Oncoimmunology. 2020. PMID: 33224629 Free PMC article.

10

MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model.

Liu C, Xie Y, Sun B, Geng F, Zhang F, Guo Q, Wu H, Yu B, Wu J, Yu X, Kong W, Zhang H. Liu C, et al. Among authors: geng f. Scand J Immunol. 2018 Feb;87(2):63-72. doi: 10.1111/sji.12633. Scand J Immunol. 2018. PMID: 29193199 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

852 results

Search Page

Filters